Increased hippocampal CA1 density of serotonergic terminals in a triple transgenic mouse model of Alzheimer's disease: an ultrastructural study

被引:0
作者
H N Noristani
R S Meadows
M Olabarria
A Verkhratsky
J J Rodríguez
机构
[1] Faculty of Life Sciences,Department of Neurosciences
[2] The University of Manchester,undefined
[3] Institute of Experimental Medicine,undefined
[4] ASCR,undefined
[5] IKERBASQUE,undefined
[6] Basque Foundation for Science,undefined
[7] University of the Basque Country UPV/EHU,undefined
[8] Instituto de Investigación Sanitaria Biodonostia,undefined
[9] Hospital Donostia,undefined
来源
Cell Death & Disease | 2011年 / 2卷
关键词
Alzheimer's disease; serotonin; serotonin transporter; electron microscopy; hippocampus; plasticity;
D O I
暂无
中图分类号
学科分类号
摘要
Alzheimer's disease (AD) is a neurodegenerative pathology that deteriorates mnesic functions and associated brain regions including the hippocampus. Serotonin (5-HT) has an important role in cognition. We recently demonstrated an increase in 5-HT transporter (SERT) fibre density in the hippocampal CA1 in an AD triple transgenic mouse model (3xTg-AD). Here, we analyse the ultrastructural localisation, distribution and numerical density (Nv) of hippocampal SERT axons (SERT-Ax) and terminals (SERT-Te) and their relationship with SERT fibre sprouting and altered synaptic Nv in 3xTg-AD compared with non-transgenic control mice. 3xTg-AD animals showed a significant increase in SERT-Te Nv in CA1 at both, 3 (95%) and 18 months of age (144%), being restricted to the CA1 stratum moleculare (S. Mol; 227% at 3 and 180% at 18 months). 3xTg-AD animals also exhibit reduced Nv of perforated axospinous synapses (PS) in CA1 S. Mol (56% at 3 and 52% at 18 months). No changes were observed in the Nv of symmetric and asymmetrical synapses or SERT-Ax. Our results suggest that concomitant SERT-Te Nv increase and PS reduction in 3xTg-AD mice may act as a compensatory mechanism maintaining synaptic efficacy as a response to the AD cognitive impairment.
引用
收藏
页码:e210 / e210
相关论文
共 212 条
[1]  
Braak E(1999)Neuropathology of Alzheimer's disease: what is new since A. Alzheimer? Eur Arch Psychiatry Clin Neurosci 249 14-22
[2]  
Griffing K(2002)Alzheimer's disease is a synaptic failure Science 298 789-791
[3]  
Arai K(2010)Neurodegenerative diseases: failures in brain connectivity? Cell Death Differ 17 1069-1070
[4]  
Bohl J(2000)Donepezil for mild and moderate Alzheimer's disease Cochrane Database Syst Rev 4 CD001190-810
[5]  
Bratzke H(2011)Reduced hippocampal glutamate in Alzheimer disease Neurobiol Aging 32 802-487
[6]  
Braak H(2007)Does serotonin augmentation have any effect on cognition and activities of daily living in Alzheimer's dementia? A double-blind, placebo-controlled clinical trial J Clin Psychopharmacol 27 484-79
[7]  
Selkoe DJ(2010)Serotonin fibre sprouting and increase in serotonin transporter immunoreactivity in the CA1 area of hippocampus in a triple transgenic mouse model of Alzheimer's disease Eur J Neurosci 32 71-582
[8]  
Knight RA(1999)Projections of the median raphe nucleus in the rat J Comp Neurol 407 555-2486
[9]  
Verkhratsky A(2006)Serotonin and human cognitive performance Curr Pharm Des 12 2473-449
[10]  
Birks JS(2005)Cholinergic-serotonergic imbalance contributes to cognitive and behavioral symptoms in Alzheimer's disease Neuropsychologia 43 442-13814